Presenting Author: Sharat Singh, PhD, Head of Research, Biora Therapeutics, Inc. About the BioJet™ Systemic Oral Delivery PlatformBiora's BioJet systemic oral therapeutics platform uses an ingestible ...
The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc. (Vancouver BC, Canada) have developed a novel oral ...
Dr. Singh will also participate in a panel discussion on June 19 at 8:45 AM titled “Uncovering Innovations in Peptide Drug Delivery & Formulation for Improved Bioavailability,” alongside ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the ...
Highly potent but poorly water-soluble drug (PWSD) candidates are common outcomes of contemporary drug discovery programmes. These lipophilic compounds often exhibit poor systemic exposure following ...
Study published in Molecular Therapy found factors affecting pharmacodynamics and described stability. Alnylam Pharmaceuticals and researchers from the Massachusetts Institute of Technology (MIT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback